TEZARTIS

Welcome to the Brand page for “TEZARTIS”, which is offered here for Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents;.

Its status is currently believed to be active. Its class is unavailable. “TEZARTIS” is believed to be currently owned by “BRISTOL-MYERS SQUIBB COMPANY”.

Owner:
BRISTOL-MYERS SQUIBB COMPANY
Owner Details
Description:
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents;
Categories: PHARMACEUTICAL PREPARATIONS HUMAN USE